PRRSV CN Porcine Test Kit Porcine Blue Ear Disease PCR Rapid Test Kit

Porcine reproductive and respiratory disorders syndrome(CN) Nucleic Acid Detection Kit (PCR-Fluorescent Probe Method)

Intended use:

This kit is used for the diagnosis, monitoring and epidemiological investigation of porcine blue ear disease, and is suitable for the specific detection of Porcine Reproductive and respiratory syndrome virus-Chinese strain/highly pathogenic (PRRSV-CN) in pig serum, oral swab, lung lavage fluid, semen, tissue (lung, lymph node, tonsil, spleen, etc.).

Principle:

This kit uses RNA as a template and primers as a starting point to synthesize cDNA strands complementary to RNA template under the action of high-efficiency reverse transcriptase. Selection of porcine reproductive and respiratory syndrome virus - China/highly pathogenic strains conservative design specific gene probe, the probe can with primer amplification area in the middle of a specific binding DNA template, in the process of PCR extension, the circumscribed Taq polymerase enzymes from the 5 'end of fluorescent groups on the probe will be cut down, make it free in the reaction system, Thus, the 3 '-end quenched group was separated, and fluorescence was emitted, which was detected by fluorescence PCR instrument to realize the detection of Porcine reproductive and respiratory syndrome virus-Chinese strain/highly pathogenic nucleic acid in a completely closed reaction system.

Main components:

Bio key Health is a high-tech enterprise with integrating R&D, production and sales&marketing in Guangzhou. Since 2003. Bio Key was founded by the "Thousand Talents Program" entrepreneurial team and the overseas senior automation equipment development engineer team.

The company's core team has been in the field of IVD research and entrepreneurship for more than 10 years, and has mastered a wealth of molecular diagnostic POCT industrial application technology, SmartTRF immune detection technology, RT qPCR nucleic acid detection technology and independent research and development capabilities of instruments.

It has a number of independent core technologies in the fields of automation engineering, micro-precision manufacturing, immunofluorescence, nucleic acid detection and gene sequencing. Since its establishment, the company has applied for more than 60 patents and currently has 17 authorized patents. The company has two R&D centers for diagnostic reagents and instruments and equipment, totaling more than 500 square meters; it has established more than 2,000 square meters of GMP workshops and equipment production plants; it has SmartTRF new immune detection technology, nucleic acid detection technology (POCT) and three scientific services.